{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:56:35Z","timestamp":1767952595804,"version":"3.49.0"},"reference-count":18,"publisher":"Termedia Sp. z.o.o.","issue":"3","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:p>Drug-induced hypersensitivity syndrome (DiHS) or drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a\u00a0severe adverse drug-induced reaction characterized by various symptoms: skin rash, fever, lymph node enlargement and internal organ involvement, which starts within 2 weeks to 3 months after drug initiation. It is challenging to diagnose this syndrome due to the variety of cutaneous and visceral symptoms. Different mechanisms have been implicated in its development, including genetic susceptibility associated with human leucocyte antigen (HLA) loci, detoxification defects leading to reactive metabolite formation and subsequent immunological reactions, slow acetylation, and reactivation of human herpes, including Epstein-Barr virus and human herpes virus (HHV)-6 and HHV-7. The most frequently reported causes of DiHS\/DRESS are antiepileptic agents, allopurinol and sulfonamides. We report a\u00a0case of DiHS\/DRESS induced by second-line treatment for tuberculosis, prothionamide and para-aminosalicylic acid, and Epstein-Barr virus re-infection. Patch testing, which was performed in this case, is not fully standardized, but it can be helpful and a\u00a0safe way to evaluate and diagnose DiHS\/DRESS.<\/jats:p>","DOI":"10.5114\/ceji.2021.109670","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T04:46:58Z","timestamp":1634791618000},"page":"401-404","source":"Crossref","is-referenced-by-count":1,"title":["DiHS\/DRESS syndrome induced by second-line treatment for tuberculosis and Epstein-Barr virus"],"prefix":"10.5114","volume":"46","author":[{"given":"Ieva","family":"Bajoriuniene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta","family":"Musteikiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agne","family":"Ramonaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigita","family":"Sitkauskiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"ref-1540670","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub P","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, et al. (2011): The DRESS syndrome: a literature review. Am J Med 124: 588-597.","journal-title":"Am J Med"},{"key":"ref-1540671","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet H","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC (1996): Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 15: 250-257.","journal-title":"Semin Cutan Med Surg"},{"key":"ref-1540672","first-page":"46ra62","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"46","author":"Picard D","year":"2010","unstructured":"Picard D, Janela B, Descamps V, et al. (2010): Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 46: 46ra62.","journal-title":"Sci Transl Med"},{"key":"ref-1540673","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jmii.2014.06.012","article-title":"Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection","volume":"48","author":"Nanishi E","year":"2015","unstructured":"Nanishi E, Hoshina T, Ohga S, et al. (2015): Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection. J Microbiol Immunol Infect 48: 109-112.","journal-title":"J Microbiol Immunol Infect"},{"key":"ref-1540674","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.coi.2012.07.010","article-title":"Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis","volume":"24","author":"Camous X","year":"2012","unstructured":"Camous X, Calbo S, Picard D, et al. (2012): Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis. Curr Opin Immunol 24: 730-735.","journal-title":"Curr Opin Immunol"},{"key":"ref-1540675","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud A","year":"2001","unstructured":"Barbaud A, Gon\u00e7alo M, Bruynzeel D, et al. (2001): European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 45: 321-328.","journal-title":"Contact Dermatitis"},{"key":"ref-1540676","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaip.2015.05.001","article-title":"A practical guide to patch testing","volume":"3","author":"Fonacier L","year":"2015","unstructured":"Fonacier L (2015): A practical guide to patch testing. J Allergy Clin Immunol Pract 3: 669-675.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref-1540677","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaip.2016.10.009","article-title":"Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study","volume":"5","author":"Hansel K","year":"2017","unstructured":"Hansel K, Bellini V, Bianchi L, et al. (2017): Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study. J Allergy Clin Immunol Pract 5: 808-810.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref-1540678","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"46","author":"Chen YC","year":"2010","unstructured":"Chen YC, Chiu HC, Chu CY (2010): Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 46: 1373-1379.","journal-title":"Arch Dermatol"},{"key":"ref-1540679","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun SH","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. (2013): Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169: 1071-1080.","journal-title":"Br J Dermatol"},{"key":"ref-1540680","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tube.2012.10.010","article-title":"Antituberculosis drug-induced hypersensitivity syndrome and its association with human leukocyte antigen","volume":"93","author":"Kim SH","year":"2013","unstructured":"Kim SH, Lee SK, Kim SH, et al. (2013): Antituberculosis drug-induced hypersensitivity syndrome and its association with human leukocyte antigen. Tuberculosis (Edinb) 93: 270-274.","journal-title":"Tuberculosis (Edinb)"},{"key":"ref-1540681","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jaip.2017.11.021","article-title":"Antituberculosis drug-associated DRESS: a case series","volume":"6","author":"Allouchery M","year":"2018","unstructured":"Allouchery M, Logerot S, Cottin J, et al. (2018): Antituberculosis drug-associated DRESS: a case series. J Allergy Clin Immunol Pract 6: 1373-1380.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref-1540682","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2012.11.008","article-title":"A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid","volume":"110","author":"Kim JH","year":"2013","unstructured":"Kim JH, Jang SH, Kim DH, et al. (2013): A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid. Ann Allergy Asthma Immunol 110: 118-119.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref-1540683","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer W","year":"2003","unstructured":"Aberer W, Bircher A, Romano A, et al. (2003): Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 58: 854-863.","journal-title":"Allergy"},{"key":"ref-1540684","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago F","year":"2010","unstructured":"Santiago F, Gon\u00e7alo M, Vieira R, et al. (2010): Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 62: 47-53.","journal-title":"Contact Dermatitis"},{"key":"ref-1540685","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"71","author":"Mayorga C","year":"2016","unstructured":"Mayorga C, Celik G, Rouzaire P, et al. (2016): In vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI Drug Allergy Interest Group position paper. Allergy 71: 1103-1134.","journal-title":"Allergy"},{"key":"ref-1540686","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019","volume":"68","author":"Shiohara T","year":"2019","unstructured":"Shiohara T, Mizukawa Y (2019): Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int 68: 301-308.","journal-title":"Allergol Int"},{"key":"ref-1540687","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2334-10-49","article-title":"Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review","volume":"10","author":"Gentile I","year":"2010","unstructured":"Gentile I, Talamo M, Borgia G (2010): Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC Infect Dis 10: 49.","journal-title":"BMC Infect Dis"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-136495-129701","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-136495-129701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:33:57Z","timestamp":1767947637000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/DiHS-DRESS-syndrome-induced-by-second-line-treatment-for-tuberculosis-and-Epstein,136495,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["136495"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2021.109670","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}